儿童特发性矮小临床治疗新进展  

Recent advances in the clinical treatment of idiopathic short stature children

作　　者：黄晓萍[1] 王伟[1] 

机构地区：[1]上海交通大学医学院附属瑞金医院儿内科,上海200025

出　　处：《临床儿科杂志》2008年第5期438-441,共4页Journal of Clinical Pediatrics

摘　　要：特发性矮小是一种在儿童中较常见的身材矮小,其病因及发病机制尚不明了,迄今尚无确切的治疗方案。目前对儿童特发性矮小的临床治疗主要集中在重组人生长激素(rhGH)、促性腺激素释放激素类似物(Gn-RHa)和芳香化酶抑制剂(AI)。文章就其新研究新进展进行综述。Idiopathic short stature （ISS） is one of the common short statures in children. The causes and pathogenesis of ISS are still unclear,there is no specific treatment guide. Recent advances in the treatment of recombinant human growth hormone,gonadotropin-releasing hormone analogue, aromatase inhibitor in children with ISS were reviewed in detail.

关 键 词：特发性矮小 生长激素 健性腺激素释放激素类似物 芳香化酶抑制剂 儿童 

分 类 号：R725.8[医药卫生—儿科]